Filing Details

Accession Number:
0001209191-13-036101
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-10 16:44:02
Reporting Period:
2013-07-08
Filing Date:
2013-07-10
Accepted Time:
2013-07-10 16:44:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1552047 L Kenneth Horton C/O Vertex Pharmaceuticals Incorporated
130 Waverly St.
Cambridge MA 02139
Evp & Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-07-08 1,513 $80.50 20,976 No 4 S Direct
Common Stock Disposition 2013-07-08 300 $81.82 20,676 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 366 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $80.50 (range $80.17 to $80.84).
  3. Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $81.82 (range $81.61 to $82.19).